IL-11 has a specific effect on hematopoietic cells, being responsible for platelet production; therefore, recombinant human IL-11 (rhIL-11) has been used as an anti-inflammatory agent to treat chemotherapy-associated thrombocytopenia. Here, IL11 is linked to Thrombocytopenia.